Your browser doesn't support javascript.
loading
mTOR inhibition by TAK-228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models.
Tang, Lanlan; Fu, Yu; Song, Jiarun; Hu, Taibing; Li, Kun; Li, Zhi.
Afiliação
  • Tang L; Department of Ophthalmology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Fu Y; Department of Ophthalmology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Song J; Department of Ophthalmology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Hu T; Department of Orthopaedic, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Li K; Department of Ophthalmology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Li Z; Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Pharmacol Res Perspect ; 10(1): e00930, 2022 02.
Article em En | MEDLINE | ID: mdl-35142090
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Retinoblastoma / Benzoxazóis / Neoplasias da Retina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Retinoblastoma / Benzoxazóis / Neoplasias da Retina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China